Platinum Investment Management LTD Alnylam Pharmaceuticals, Inc. Transaction History

Platinum Investment Management LTD

  • $2.43 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 06, 2020
SELL
$104.21 - $156.44 $1.36 Million - $2.04 Million
-13,021 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$93.12 - $133.99 $253,286 - $364,452
-2,720 Reduced 17.28%
13,021 $1.42 Million
Q4 2019

Feb 13, 2020
SELL
$74.51 - $124.23 $515,162 - $858,926
-6,914 Reduced 30.52%
15,741 $1.81 Million
Q2 2019

Aug 14, 2019
BUY
$65.86 - $92.79 $1.49 Million - $2.1 Million
22,655 New
22,655 $1.64 Million

Others Institutions Holding ALNY

# of Institutions
585
Shares Held
104M
Call Options Held
2.82M
Put Options Held
1.75M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.5B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Platinum Investment Management LTD Portfolio

Follow Platinum Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Platinum Investment Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email